CAM
IRWD icon

ClariVest Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

ClariVest Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-95,682
Closed -$833K – 897
2024
Q1 		$833K Sell
95,682
-816
-0.8% -$9.9K 0.09% 301
2023
Q4 		$1.1M Sell
96,498
-83
-0.1% -$821 0.06% 233
2023
Q3 		$930K Buy
96,581
+152
+0.2% +$1.49K 0.05% 246
2023
Q2 		$1.03M Sell
96,429
-19,725
-17% -$212K 0.05% 244
2023
Q1 		$1.22M Sell
116,154
-114
-0.1% -$1.28K 0.05% 258
2022
Q4 		$1.44M Sell
116,268
-33,119
-22% -$376K 0.07% 216
2022
Q3 		$1.55M Sell
149,387
-45,782
-23% -$519K 0.07% 191
2022
Q2 		$2.25M Sell
195,169
-91,560
-32% -$1.08M 0.1% 174
2022
Q1 		$3.61M Sell
286,729
-29,484
-9% -$338K 0.14% 151
2021
Q4 		$3.69M Sell
316,213
-28,625
-8% -$351K 0.11% 177
2021
Q3 		$4.5M Sell
344,838
-17,546
-5% -$227K 0.15% 151
2021
Q2 		$4.66M Buy
362,384
+141,199
+64% +$1.62M 0.16% 139
2021
Q1 		$2.47M Buy
221,185
+11,376
+5% +$120K 0.09% 187
2020
Q4 		$2.39M Sell
209,809
-86,696
-29% -$949K 0.08% 194
2020
Q3 		$2.67M Buy
296,505
+188,663
+175% +$1.88M 0.09% 180
2020
Q2 		$1.11M Buy
+107,842
New +$1.1M 0.03% 310
2020
Q1 		– Sell
-78,326
Closed -$1.04M – 727
2019
Q4 		$1.04M Sell
78,326
-52,961
-40% -$584K 0.02% 346
2019
Q3 		$1.13M Sell
131,287
-1,600
-1% -$15.5K 0.03% 332
2019
Q2 		$1.46M Buy
+132,887
New +$1.49M 0.03% 282

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ClariVest Asset Management's IRWD Position: Q2 2024 in Review

ClariVest Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 95,682 shares — an estimated $833K sold.

ClariVest Asset Management first reported a position in IRWD in Q2 2019 and held it in 19 quarters. The position peaked at $4.66M in Q2 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • ClariVest Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • ClariVest Asset Management sold 95,682 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $833K.
  • ClariVest Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 19 quarters.
  • ClariVest Asset Management's Ironwood Pharmaceuticals position peaked at $4.66M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.